Kane Biotech Inc.
KNBIF
Price:
$0.025
Market Cap:
$4.99M
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorpo...[Read more]
Industry
Biotechnology
IPO Date
2007-08-07
Stock Exchange
OTC
Ticker
KNBIF
PE Ratio
[-2.50]
ROE
[211.08%]
Current Ratio
[1.20]
Dividend Yield
[0%]
Enterprise Value
[5.98M]
Dividend History
The Current Ratio as of December 2025 (TTM) for Kane Biotech Inc. (KNBIF) is 1.20
According to Kane Biotech Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.20. This represents a change of 60.70% compared to the average of 0.75 of the last 4 quarters.
Kane Biotech Inc. (KNBIF) Historical Current Ratio (quarterly & annually)
How has KNBIF Current Ratio performed in the past?
The mean historical Current Ratio of Kane Biotech Inc. over the last ten years is 1.07. The current 1.20 Current Ratio has changed 11.20% with respect to the historical average. Over the past ten years (40 quarters), KNBIF's Current Ratio was at its highest in in the June 2023 quarter at 371.67K. The Current Ratio was at its lowest in in the March 2019 quarter at 0.24.
Average
1.07
Median
0.77
Minimum
0.27
Maximum
3.41
Kane Biotech Inc. (KNBIF) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Kane Biotech Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 426.78%
Maximum Annual Current Ratio = 3.41
Minimum Annual Increase = -92.09%
Minimum Annual Current Ratio = 0.27
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.43 | 24.92% |
| 2023 | 0.34 | -30.02% |
| 2022 | 0.49 | -19.96% |
| 2021 | 0.61 | -34.85% |
| 2020 | 0.94 | -34.19% |
| 2019 | 1.42 | 426.78% |
| 2018 | 0.27 | -92.09% |
| 2017 | 3.41 | 146.55% |
| 2016 | 1.38 | 2.25% |
| 2015 | 1.35 | -22.30% |
Kane Biotech Inc. (KNBIF) Average Current Ratio
How has KNBIF Current Ratio performed in the past?
The current Current Ratio of Kane Biotech Inc. (KNBIF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.42
5-year avg
0.56
10-year avg
1.07
Kane Biotech Inc. (KNBIF) Current Ratio vs. Peers
How is KNBIF’s Current Ratio compared to its peers?
Kane Biotech Inc.’s Current Ratio is greater than Bioxytran, Inc. (0.00), greater than MYND Life Sciences Inc. (0.14), greater than Burzynski Research Institute, Inc. (0.02), greater than ProText Mobility, Inc. (0), less than Futura Medical plc (2.47), greater than BioVaxys Technology Corp. (0.29), less than Glow Lifetech Corp. (2.24), greater than Theralink Technologies, Inc. (0.03), greater than Predictmedix Inc. (0.20), greater than WEED, Inc. (0.02),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.00 | $7.04M | |
| 0.14 | $1.71M | |
| 0.02 | $5.78M | |
| 0 | $9.11M | |
| 2.47 | $6.10M | |
| 0.29 | $4.54M | |
| 2.24 | $7.21M | |
| 0.03 | $615.15K | |
| 0.20 | $12.06M | |
| 0.02 | $6.24M |
Build a custom stock screener for Kane Biotech Inc. (KNBIF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kane Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kane Biotech Inc. (KNBIF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kane Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Kane Biotech Inc.'s Current Ratio?
How is the Current Ratio calculated for Kane Biotech Inc. (KNBIF)?
What is the highest Current Ratio for Kane Biotech Inc. (KNBIF)?
What is the 3-year average Current Ratio for Kane Biotech Inc. (KNBIF)?
What is the 5-year average Current Ratio for Kane Biotech Inc. (KNBIF)?
How does the current Current Ratio for Kane Biotech Inc. (KNBIF) compare to its historical average?